Allogeneic cytotoxic T lymphocytes can mediate graft-versus-leukemia without causing graft-versus-host disease.

被引：0
|
作者：
Boyer, MW
Johnson, TS
Yeager, AM
Waller, EK
机构：
[1] EMORY UNIV,DEPT PEDIAT,ATLANTA,GA 30322
[2] EMORY UNIV,DEPT MED,ATLANTA,GA 30322
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：964 / 964
页数：1
相关论文
共 50 条
  • [31] Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects
    Ehx, Gregory
    Fransolet, Gilles
    de Leval, Laurence
    D'Hondt, Stephanie
    Lucas, Sophie
    Hannon, Muriel
    Delens, Loic
    Dubois, Sophie
    Drion, Pierre
    Beguin, Yves
    Humblet-Baron, Stephanie
    Baron, Frederic
    ONCOIMMUNOLOGY, 2017, 6 (05):
  • [32] Suicide gene therapy with central memory human T lymphocytes for a graft-versus-leukemia effect and control of graft-versus-host disease
    Bondanza, Attilio
    Kaneko, Shin
    Hambach, Lothar
    Mastaglio, Sara
    Ponzoni, Maurilio
    Aldrighetti, Luca
    Toma, Salvatore
    Radrizzani, Marina
    Catamancio, Simona La Seta
    Ciceri, Fabio
    Bordignon, Claudio
    Goulmy, Els
    Bonini, Chiara
    HUMAN GENE THERAPY, 2007, 18 (10) : 979 - 980
  • [33] T-helper cells: Their role in the pathogenesis of graft-versus-host disease and graft-versus-leukemia effect
    Bunjes, D
    Theobald, M
    Nierle, T
    Hertenstein, B
    Merk, B
    Stefanic, M
    Novotny, J
    Arnold, R
    Heimpel, H
    BONE MARROW AND PERIPHERAL STEM CELL TRANSPLANTATION: MEDICAL PROBLEMS IN THE POSTTRANSPLANTATION PHASE AND REHABILITATION STRATEGIES, 1996, : 38 - 65
  • [34] T cells, graft-versus-host disease and graft-versus-leukemia: Innovative approaches for blood and marrow transplantation
    Champlin, R
    Giralt, S
    Gajewski, J
    ACTA HAEMATOLOGICA, 1996, 95 (3-4) : 157 - 163
  • [35] Notch inhibition enhances graft-versus-leukemia while reducing graft-versus-host disease
    Luo, Xiaodan
    Xu, Lihua
    Liu, Lian
    Li, Yangqiu
    Tan, Huo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 843 : 226 - 232
  • [36] Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease
    Morecki, S
    Slavin, S
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 355 - 366
  • [37] Expansion of Large Granular Lymphocytes Following Allogeneic Stem Cell Transplantation: Its Association with Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect
    Kim, Dong Hwan
    Al-Dawsari, Ghuzayel
    Jung, Chul Won
    Hong, Chang
    Kamel-Reid, Suzanne
    Wright, Janice
    Galal, Ahmed
    Gupta, Vikas
    Kuruvilla, John
    Lipton, Jeffrey H.
    Messner, Hans A.
    BLOOD, 2009, 114 (22) : 888 - 888
  • [38] Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
    Schmaltz, C
    Alpdogan, O
    Horndasch, KJ
    Muriglan, SJ
    Kappel, BJ
    Teshima, T
    Ferrara, JLM
    Burakoff, SJ
    van den Brink, MRM
    BLOOD, 2001, 97 (09) : 2886 - 2895
  • [39] INTERLEUKIN-2 PREVENTS GRAFT-VERSUS-HOST DISEASE WHILE PRESERVING THE GRAFT-VERSUS-LEUKEMIA EFFECT OF ALLOGENEIC T-CELLS
    SYKES, M
    ROMICK, ML
    SACHS, DH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) : 5633 - 5637
  • [40] IMPACT OF HLA DISPARITIES ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA REACTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    JACOBSEN, N
    JAKOBSEN, B
    MADSEN, H
    LUND, B
    VINDELOV, L
    GEISLER, C
    HEILMANN, C
    RUSSELL, L
    LAMM, L
    SVEJGAARD, A
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 862 - 862
12345